Principal Investigator
Aman Chauhan
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20231132
Clinical Trial Summary
Phase 1b single arm, open-label trial of RYZ101 in combination with carboplatin + etoposide + atezolizumab in subjects with somatostatin receptor expressing (SSTR+) extensive stage small cell lung cancer (ES-SCLC)
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Phase I
Contact Information
Phone Number
305-243-2647